Pilocytic astrocytoma Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

🩺

19Specialists

Regulatory Watchboard

No FDA or trial events recorded yet for Pilocytic astrocytoma.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Pilocytic astrocytoma.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Ojemda

(tovorafenib)Orphan drug

Day One Biopharmaceuticals, Inc.

Kinase Inhibitor [EPC]

12.1 Mechanism of Action Tovorafenib is a Type II RAF kinase inhibitor of mutant BRAF V600E , wild-type BRAF , and wild-type CRAF kinases. Tovorafenib...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Pilocytic astrocytoma.
Search all trials →

Search clinical trials for Pilocytic astrocytoma →

Recent News & Research

No recent news articles indexed yet for Pilocytic astrocytoma.
Search PubMed for Pilocytic astrocytoma →

Browse all Pilocytic astrocytoma news →

Specialist Network

Top 6 by expertise

Stanislaw R. Burzynski, MD, PhD, M.D., Ph.D

Burzynski Research Institute

📍 HOUSTON, TX

Score 929 trials

Giles W. Robinson, MD, M.D

St. Jude Children's Research Hospital

📍 MEMPHIS, TN

Score 94 trials1 pub

Julie Krystal, MD, MD

Northwell Health

📍 NEW HYDE PARK, NY

Score 71 trial

Ernest C. Borden, MD

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Score 75 trials

Patrick Wen, MD, MD

National Cancer Institute (NCI)

📍 BOSTON, MA

Score 76 trials

Stephen Rapp, PhD

Wake Forest University Health Sciences

Score 61 trial

View all Pilocytic astrocytoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰